75 related articles for article (PubMed ID: 1713059)
1. Human immunodeficiency virus reverse transcriptase ribonuclease H: specificity of tRNA(Lys3)-primer excision.
Furfine ES; Reardon JE
Biochemistry; 1991 Jul; 30(29):7041-6. PubMed ID: 1713059
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.
Wei X; Götte M; Wainberg MA
Nucleic Acids Res; 2000 Aug; 28(16):3065-74. PubMed ID: 10931921
[TBL] [Abstract][Full Text] [Related]
3. New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3.
Wu C; Nerurkar VR; Lu Y
Retrovirology; 2013 Oct; 10():112. PubMed ID: 24156557
[TBL] [Abstract][Full Text] [Related]
4. In vivo Ty1 reverse transcription can generate replication intermediates with untidy ends.
Mules EH; Uzun O; Gabriel A
J Virol; 1998 Aug; 72(8):6490-503. PubMed ID: 9658092
[TBL] [Abstract][Full Text] [Related]
5. Dual coding potential of a 2',5'-branched ribonucleotide in DNA.
Döring J; Hurek T
RNA; 2019 Jan; 25(1):105-120. PubMed ID: 30361268
[TBL] [Abstract][Full Text] [Related]
6. Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmission.
Sundaravaradan V; Hahn T; Ahmad N
Retrovirology; 2005 May; 2():36. PubMed ID: 15918905
[TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Aspects of Foamy Virus Protease-Reverse Transcriptase.
Wöhrl BM
Viruses; 2019 Jul; 11(7):. PubMed ID: 31269675
[TBL] [Abstract][Full Text] [Related]
8. RNase H sequence preferences influence antisense oligonucleotide efficiency.
Kielpinski LJ; Hagedorn PH; Lindow M; Vinther J
Nucleic Acids Res; 2017 Dec; 45(22):12932-12944. PubMed ID: 29126318
[TBL] [Abstract][Full Text] [Related]
9. LEDGF/p75 Deficiency Increases Deletions at the HIV-1 cDNA Ends.
Bueno MTD; Reyes D; Llano M
Viruses; 2017 Sep; 9(9):. PubMed ID: 28914817
[TBL] [Abstract][Full Text] [Related]
10. SiRNA-induced mutation in HIV-1 polypurine tract region and its influence on viral fitness.
Rausch JW; Tian M; Li Y; Angelova L; Bagaya BS; Krebs KC; Qian F; Zhu C; Arts EJ; Le Grice SF; Gao Y
PLoS One; 2015; 10(4):e0122953. PubMed ID: 25860884
[TBL] [Abstract][Full Text] [Related]
11. Insights into the structure and activity of prototype foamy virus RNase H.
Leo B; Hartl MJ; Schweimer K; Mayr F; Wöhrl BM
Retrovirology; 2012 Feb; 9():14. PubMed ID: 22325739
[TBL] [Abstract][Full Text] [Related]
12. Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.
Farias RV; Vargas DA; Castillo AE; Valenzuela B; Coté ML; Roth MJ; Leon O
Antimicrob Agents Chemother; 2011 Oct; 55(10):4735-41. PubMed ID: 21768506
[TBL] [Abstract][Full Text] [Related]
13. Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.
Götte M; Rausch JW; Marchand B; Sarafianos S; Le Grice SF
Biochim Biophys Acta; 2010 May; 1804(5):1202-12. PubMed ID: 19665597
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition.
Beilhartz GL; Wendeler M; Baichoo N; Rausch J; Le Grice S; Götte M
J Mol Biol; 2009 May; 388(3):462-74. PubMed ID: 19289131
[TBL] [Abstract][Full Text] [Related]
15. Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.
Champoux JJ; Schultz SJ
FEBS J; 2009 Mar; 276(6):1506-16. PubMed ID: 19228195
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition.
Sarafianos SG; Marchand B; Das K; Himmel DM; Parniak MA; Hughes SH; Arnold E
J Mol Biol; 2009 Jan; 385(3):693-713. PubMed ID: 19022262
[TBL] [Abstract][Full Text] [Related]
17. The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.
Chang KW; Oh J; Alvord WG; Hughes SH
J Virol; 2008 Sep; 82(17):8592-604. PubMed ID: 18562520
[TBL] [Abstract][Full Text] [Related]
18. RNase H activity: structure, specificity, and function in reverse transcription.
Schultz SJ; Champoux JJ
Virus Res; 2008 Jun; 134(1-2):86-103. PubMed ID: 18261820
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.
Oh J; McWilliams MJ; Julias JG; Hughes SH
J Virol; 2008 Jan; 82(2):719-27. PubMed ID: 17989171
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
